Opening book details…
About this Medicine article
Phase I study of the heat shock protein 90 (Hsp90) inhibitor onalespib (AT13387) administered on a daily for 2 consecutive days per week dosing schedule in patients with advanced solid tumors by Do, Khanh; Speranza, Giovanna; Chang, Lun-Ching; Polley, Eric C.; Bishop, Rachel; Zhu, Weimin; Trepel, Jane B.; Lee, Sunmin; Lee, Min-Jung; Kinders, Robert J.; Phillips, Larry; Collins, Jerry; Lyons, John; Jeong, Woondong; Antony, Ramya; Chen, Alice P.; Neckers, Len; Doroshow, James H.; Kummar, Shivaani is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Do, Khanh; Speranza, Giovanna; Chang, Lun-Ching; Polley, Eric C.; Bishop, Rachel; Zhu, Weimin; Trepel, Jane B.; Lee, Sunmin; Lee, Min-Jung; Kinders, Robert J.; Phillips, Larry; Collins, Jerry; Lyons, John; Jeong, Woondong; Antony, Ramya; Chen, Alice P.; Neckers, Len; Doroshow, James H.; Kummar, Shivaani
- Publisher
- Springer US; Springer-Verlag; Kluwer Academic Publishers; Springer Science and Business Media LLC (ISSN 0167-6997)
- Published
- 2015
- Field
- Medicine (Health Sciences)